227 related articles for article (PubMed ID: 10078632)
21. Influence of intraluminal brachytherapy dose on complications in the treatment of esophageal cancer.
Kumar MU; Swamy K; Supe SS; Anantha N
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1069-72. PubMed ID: 8262829
[TBL] [Abstract][Full Text] [Related]
22. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
Ferrigno R; dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Gentil AC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1123-35. PubMed ID: 11483321
[TBL] [Abstract][Full Text] [Related]
23. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
[TBL] [Abstract][Full Text] [Related]
24. Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.
Tamaki T; Ishikawa H; Takahashi T; Tamaki Y; Kitamoto Y; Okamoto M; Noda SE; Katoh H; Shirai K; Sakurai H; Nakano T
Brachytherapy; 2012; 11(2):130-6. PubMed ID: 21700506
[TBL] [Abstract][Full Text] [Related]
25. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
[TBL] [Abstract][Full Text] [Related]
26. High-dose-rate brachytherapy for previously irradiated patients with recurrent esophageal cancer.
Nonoshita T; Sasaki T; Hirata H; Toh Y; Shioyama Y; Nakamura K; Honda H
Radiat Med; 2007 Oct; 25(8):373-7. PubMed ID: 17952540
[TBL] [Abstract][Full Text] [Related]
27. Combined endoluminal and external irradiation of inoperable oesophageal carcinoma.
Schraube P; Fritz P; Wannenmacher MF
Radiother Oncol; 1997 Jul; 44(1):45-51. PubMed ID: 9288857
[TBL] [Abstract][Full Text] [Related]
28. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
[TBL] [Abstract][Full Text] [Related]
29. Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation.
Nishimura Y; Ono K; Tsutsui K; Oya N; Okajima K; Hiraoka M; Abe M
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1099-105. PubMed ID: 7961017
[TBL] [Abstract][Full Text] [Related]
30. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
31. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.
Calais G; Dorval E; Louisot P; Bourlier P; Klein V; Chapet S; Reynaud-Bougnoux A; Huten N; De Calan L; Aget H; Le Floch O
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):769-75. PubMed ID: 9240645
[TBL] [Abstract][Full Text] [Related]
32. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
Kim WC; Kim GE; Suh CO; Loh JJ
Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
[TBL] [Abstract][Full Text] [Related]
33. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
[TBL] [Abstract][Full Text] [Related]
34. High dose rate brachytherapy for carcinoma of the uterine cervix: comparison of two different fractionation regimens.
Le Pechoux C; Akine Y; Sumi M; Tokuuye K; Ikeda H; Yajima M; Yamada T; Tanemura K; Tsunematsu R; Ohmi K
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):735-41. PubMed ID: 7860384
[TBL] [Abstract][Full Text] [Related]
35. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcomes and prognostic factors for patients with early esophageal squamous cell carcinoma treated with definitive radiation therapy alone.
Ishikawa H; Sakurai H; Yamakawa M; Saito Y; Nakayama Y; Kitamoto Y; Okamoto M; Harada K; Hasegawa M; Nakano T
J Clin Gastroenterol; 2005 Jul; 39(6):495-500. PubMed ID: 15942435
[TBL] [Abstract][Full Text] [Related]
37. Three or four fractions of 4-5 Gy per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma.
Rovirosa A; Ascaso C; Sánchez-Reyes A; Herreros A; Abellana R; Pahisa J; Lejarcegui JA; Biete A
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):418-23. PubMed ID: 20800388
[TBL] [Abstract][Full Text] [Related]
38. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.
Sur RK; Donde B; Levin VC; Mannell A
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834
[TBL] [Abstract][Full Text] [Related]
39. Early-stage esophageal squamous cell carcinoma treated with californium-252 neutron brachytherapy: clinical report on 16 cases.
Liu H; Wang Q; Jia X; Liu B; Wang CK
Tumori; 2013; 99(2):172-5. PubMed ID: 23748810
[TBL] [Abstract][Full Text] [Related]
40. Salvage high-dose-rate brachytherapy for esophageal cancer in previously irradiated patients: A retrospective analysis.
Wong Hee Kam S; Rivera S; Hennequin C; Lourenço N; Chirica M; Munoz-Bongrand N; Gornet JM; Quéro L
Brachytherapy; 2015; 14(4):531-6. PubMed ID: 25906950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]